BLFS BioLife Solutions
- 22.925
- +0.155+0.68%
BioLife Solutions News
Express News | BioLife Solutions Inc : TD Cowen Raises Target Price to $26 From $20
TD Cowen Maintains BioLife Solutions(BLFS.US) With Buy Rating, Raises Target Price to $26
TD Cowen analyst Steven Mah maintains $BioLife Solutions(BLFS.US)$ with a buy rating, and adjusts the target price from $20 to $26.According to TipRanks data, the analyst has a success rate of 26.9%
BioLife Solutions: Strong Buy Rating on Robust Gross Margins and Positive Long-Term EBITDA Outlook
BioLife Solutions, Inc. (NASDAQ:BLFS): When Will It Breakeven?
We feel now is a pretty good time to analyse BioLife Solutions, Inc.'s (NASDAQ:BLFS) business as it appears the company may be on the cusp of a considerable accomplishment. BioLife Solutions, Inc. d
BioLife Solutions(BLFS.US) Officer Sells US$63,090 in Common Stock
$BioLife Solutions(BLFS.US)$ Officer Aebersold Sarah sold 3,000 shares of common stock on Jul 1, 2024 at an average price of $21.03 for a total value of $63,090.Source: Announcement What is statement
CellFE Announces Addition of Life Science Tools Veteran Mike Rice to Board of Directors
Non-Viral Cell Therapy Manufacturing System Enables Faster Development Time and Healthier Cells vs. Electroporation ALAMEDA, Calif., June 25, 2024 /PRNewswire/ -- CellFE Inc., a cell engineering plat
A Look At The Intrinsic Value Of BioLife Solutions, Inc. (NASDAQ:BLFS)
Key Insights The projected fair value for BioLife Solutions is US$24.05 based on 2 Stage Free Cash Flow to Equity With US$19.96 share price, BioLife Solutions appears to be trading close to its esti
Insider Sale: Todd Berard Sells 10,000 Shares of BioLife Solutions Inc (BLFS)
BioLife Solutions(BLFS.US) Officer Sells US$201.8K in Common Stock
$BioLife Solutions(BLFS.US)$ Officer Berard Todd sold 10,000 shares of common stock on Jun 14, 2024 at an average price of $20.18 for a total value of $201.8K.Source: Announcement What is statement of
Northland Securities Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $26
Northland Securities analyst Carl Byrnes maintains $BioLife Solutions(BLFS.US)$ with a buy rating, and maintains the target price at $26.According to TipRanks data, the analyst has a success rate of 0
BioLife Solutions (NASDAQ:BLFS) Dips 5.5% This Week as Increasing Losses Might Not Be Inspiring Confidence Among Its Investors
While not a mind-blowing move, it is good to see that the BioLife Solutions, Inc. (NASDAQ:BLFS) share price has gained 19% in the last three months. But that cannot eclipse the less-than-impressive
BioLife Solutions (BLFS) Receives a Buy From Craig-Hallum
BioLife Solutions Introduces the CellSeal CryoCase at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver
New container developed for the needs of cell and gene therapy (CGT) primary packaging to replace cryopreservation bags with a fracture resistant, rigid construction built for both manual use and clo
Insider Sale: Chief Marketing Officer Todd Berard Sells 10,000 Shares of BioLife Solutions Inc ...
BioLife Solutions(BLFS.US) Officer Sells US$226.7K in Common Stock
$BioLife Solutions(BLFS.US)$ Officer Berard Todd sold 10,000 shares of common stock on May 15, 2024 at an average price of $22.67 for a total value of $226.7K.Source: Announcement What is statement of
Analysts Are Bullish on Top Healthcare Stocks: Fortress Biotech (FBIO), BioLife Solutions (BLFS)
Express News | BioLife Solutions Inc : Maxim Group Raises Target Price to $30 From $25
Express News | BioLife Solutions Inc : Stephens Raises Target Price to $27 From $21
Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and BioLife Solutions (BLFS)
Express News | BioLife Solutions Shares Are Trading Higher After Benchmark Ugpraded the Stock From Hold to Buy and Announced a $25 Price Target
Analysis
Price Target
No Data
